- Home
- GPMT vs KZR Comparison
GPMT vs KZR Comparison
Compare GPMT & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPMT
- KZR
- Stock Information
- Founded
- GPMT 2015
- KZR 2015
- Country
- GPMT United States
- KZR United States
- Employees
- GPMT N/A
- KZR N/A
- Industry
- GPMT Real Estate Investment Trusts
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- GPMT Real Estate
- KZR Health Care
- Exchange
- GPMT Nasdaq
- KZR Nasdaq
- Market Cap
- GPMT 122.0M
- KZR 29.7M
- IPO Year
- GPMT 2017
- KZR 2018
- Fundamental
- Price
- GPMT $2.58
- KZR $6.36
- Analyst Decision
- GPMT Buy
- KZR Hold
- Analyst Count
- GPMT 3
- KZR 4
- Target Price
- GPMT $3.13
- KZR $6.00
- AVG Volume (30 Days)
- GPMT 234.1K
- KZR 433.0K
- Earning Date
- GPMT 11-05-2025
- KZR 11-11-2025
- Dividend Yield
- GPMT 7.75%
- KZR N/A
- EPS Growth
- GPMT N/A
- KZR N/A
- EPS
- GPMT N/A
- KZR N/A
- Revenue
- GPMT N/A
- KZR N/A
- Revenue This Year
- GPMT N/A
- KZR N/A
- Revenue Next Year
- GPMT $26.51
- KZR N/A
- P/E Ratio
- GPMT N/A
- KZR N/A
- Revenue Growth
- GPMT N/A
- KZR N/A
- 52 Week Low
- GPMT $1.61
- KZR $3.53
- 52 Week High
- GPMT $3.66
- KZR $8.60
- Technical
- Relative Strength Index (RSI)
- GPMT 30.41
- KZR 84.60
- Support Level
- GPMT $2.67
- KZR $4.10
- Resistance Level
- GPMT $3.03
- KZR $4.45
- Average True Range (ATR)
- GPMT 0.09
- KZR 0.32
- MACD
- GPMT -0.04
- KZR 0.17
- Stochastic Oscillator
- GPMT 1.34
- KZR 98.72
About GPMT Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.